Adiponectin - Is it just another cytokine secreted by adipose tissue;Adiponektyna - Czy tylko kolejna cytokina wydzielana przez tkankȩ tłuszczowa̧

Diabetologia Polska

Volumn 11, Issue 3, 2004, Pages 208-213

  Zasadzińska, Grazyna ^a,b   Saryusz Wolska, Małgorzata ^a   Miłosz, Danuta ^a   Loba, Jerzy ^a  

^a Klin Diabetol/Chorob Metabolic UM   (Poland)

^b Kliniczny 1 im N Barlickiego ^*  (Poland)

Author keywords

Adiponectin; Atherosclerosis; Diabetes mellitus; Insulin resistance; Obesity

Indexed keywords

ADIPONECTIN; CYTOKINE;

ADIPOSE TISSUE; ATHEROGENESIS; CYTOKINE RELEASE; FATTY ACID OXIDATION; GLUCOSE METABOLISM; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; ISCHEMIC HEART DISEASE; KIDNEY FAILURE; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 12444250131     PISSN: 12334723     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Maeda K., Okubo K., Shimomura I. i wsp. cDNA cloning and expresion of a novel adipose specilic collagen-like factor, apM1 (AdiPose Most Abundant gene transcript 1). Biochem. Biophys. Res. Commun., 1996, 221, 286-289.
2. Nakano Y., Tobe T., Choi-Miura N.H. i wsp. Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J. Biochem., 1996, 120, 803-812
3. Scherer P.E., Williams S., Fogliano M. i wsp. A novel serum protein similar to C1q, produced exclusively in adipocytes. J. Biol. Chem., 1995, 270, 26746-26749.
4. Hu E., Liang P., Spielman B.M. Adipo Q is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem., 1996, 271, 10697-10703.
5. Saito K., Tobe T., Minoshima S. i wsp. Organization of the gene for gelatin-binding protein (GBP28). Gene, 1999, 229, 67-73.
6. Arita Y., Kihara S., Ouohi N. i wsp. Paradoxical decrease of an adipocyte specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun., 1999, 257, 79-83.
7. Fruebis J., Tsao T.S., Javorsohi S. i wsp. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight toss in mice. Proc. Natl. Acad. Sci. USA, 2001, 98, 2005-2010.
8. Yoda-Murakami M., Taniguchi M., Takahashi K. i wsp. Change in expression of GBP28/adiponectin in carbon tetrachloride-administatedmouse liver. Biochem. Biophys. Res. Commun., 2001, 285, 372-377.
9. Straiger H., Eitel K., Stumvoll M. Adiponectin expression in human non-adipose cells. Diabetologia, 2003, 46, Supl. 2, A79.
10. Zoccali C., Mallamaci F., Panuccio V. i wsp., Adiponectin is markedly increased in patients with nephrotic syndrome and is related to metabolic risk factors. Kidney. Int. Suppl., 2003, 84, S98-102.
11. Fasshauer M., Klein J., Neumann S. i wsp. Hormonal regulation of adiponectin gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun., 2002, 25, 290, 1084-9.
12. Fasshauer M., Kralisch S., Klier M. i wsp. Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun., 2003, 21, 301, 1045-50.
13. Bajaj M., Suraamornkul S., Glass L. i wsp. Pioglitazone treatment reduces hepatic fat content, enhances hepatic insulin sensitivity, and increases plasma adiponectin concentration in patients with Type 2 diabetes. Diabetologia, 2003, 46, Supl. 2, A61.
14. Schubart U., Kaplan R., Rood J. i wsp. The serum adiponectin response to rosiglitasone in type 2 diabetes is not affected by co-administration of glyburine or metformin. Diabetes, 2003, 52 Supl.1, A543
15. Maeda N., Takahashi M., Funahashi T. i wsp. PPAR gamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes, 2001, 50, 2094-9.
16. Moore G.B., Chapman H., Holder J.C. i wsp. Differential regulation of adipocytokine m RNAs by rosiglitasone in db/db mice. Biochem. Biophys. Res. Commun., 2001, 286, 735-741.
17. Fasshauer M., Klein J., Neumann S. i wsp. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett. 2001, 26, 507, 142-6.
18. Delporte M.L., Funahashi T., Takahashi M. i wsp. Pre- and post-translational negative effect of beta-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies. Biochem. J., 2002, 1, 367,677-85.
19. Yamauchi T., Kamon J., Ito Y. i wsp. Antidiabetic metabolic effects. Nature, 2003, 12, 423(6941), 762-9.
20. Kharroubi I., Rasschaert J., Eizirik D.L. i wsp. Expression of adiponectin receptors in pancreatic beta cells. Biochem. Biophys. Res. Commun., 2003, 312, 4.
21. Chinetti G., Zawadski C., Fruchart J.C. i wsp. Expression of adiponectin receptors in human macrophages and regulation by agonists of the nuclear receptors PPARalpha, PPARgamma, and LXR. Biochem. Biophys. Res. Commun., 2004, 30, 314, 151-8.
22. Yamauchi T., Kamon J., Minokoshi Y. i wsp. Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat. Med., 2002, 8, 1288-95.
23. Combs T.P., Berg A.H., Obici S. i wsp. Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J. Clin. Invest., 2001, 108, 1875-81.
24. Barger P. M., Browning A. C., Garner i wsp. P38 mitogen-activated proteinkinase activates peroxisome proliferator-activated receptor alpha: a potential role in the cardiac metabolic stress response. J. Biol. Chem., 2001, 276.
25. Shand BI., Scott R.S., Elder P.A. i wsp. Plasma adiponectin in overweight, nondiabetic individuals with or without insulin resistance. Diabetes Obes. Metab., 2003, 5, 349-53.
26. Silha J., Krsek M., Skrha J. Adipokines in diabetic obese subjects: insulin resistance, more closely correlates with resistin than leptin, adiponectin and interleucin-6. Diabetologia. 2003, 46, Supl. 2, A 199.
27. Kubota N., Terauchi Y., Yamauchi T. i wsp. Disruption of adiponectin causes insulin resistance and neointimal formation. J. Biol. Chem., 2002. 19, 277, 25863-6.
28. Weyer C., Funahashi T., Tanaka S. i wsp. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab., 2001, 86, 1930-5.
29. Halleux C.M., Takahashi M., Delporte M.L. i wsp. Secretion of adiponectin and regulation of apM1 gene expression in human visceral adipose tissue. Biochem. Biophys. Ress. Commun., 2001, 288, 1102-1107.
30. Faraj M., Havel P.J., Phelis S. i wsp. Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects, J. Clin. Endocrinol. Metab., 2003, 88, 1594-602.
31. Monzillo L.U. Hamdy O., Norton E.S. i wsp. Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes. Res., 2003, 11, 1048-54.
32. Ouchi N., Kihara S., Arita Y. i wsp. Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages. Circulation, 2001, 27, 103, 1057-63.
33. Brakenhielm E., Veitonmaki N., Cao R. i wsp. Adiponectin-induced antiangiogenesis and antitumor activity involve caspase-mediated endothetial cell apoptosis. Proc. Natl. Acad Sci. USA, 2004, 24, 101, 2476-81.
34. Shimabukuro M., Higa N., Asahi T. i wsp. Hypoadiponectinemia is closely linked to endothelial dysfunction in man. J. Clin. Endocrinol. Metab., 2003, 88, 3236-40.
35. Ouchi N., Ohishi M., Kihara S. i wsp. Association ot hypoadiponectinemia with impaired vasoreactivity. Hypertension, 2003, 42, 231-4.
36. Chen H., Montagnani M., Funahashi T. i wsp. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem., 2003, 278, 45021-6.
37. Chandran M., Phillips S.A., Ciaraldi T. i wsp. Adiponectin: more than just another fat cell hormone? Diabetes Care, 2003, 26, 2442-50.
38. Shklyaev S., Aslanidi G., Tennant M. i wsp. Sustained peripheral expression of transgene adiponectin offsets the development of diet-induced obesity in rats. Proc. Natl. Acad. Sci. USA, 2003, 25, 100, 14217-22.
39. Kosmiski L., Kuritzkes D., Lichtenstein K. i wsp. Adipocyte-derived hormone levels in HIV lipodystrophy. Antivir. Ther, 2003, 8, 9-15.